Sectors
Jurisdictions
- Australia
- Brunei
- Cambodia
- China
- Hong Kong
- India
- Indonesia
- Japan
- Laos
- Macau
- Malaysia
- Mongolia
- Myanmar
- Nepal
- New Zealand
- North Korea
- Pakistan
- Philippines
- Singapore
- South Korea
- Sri Lanka
- Taiwan
- Thailand
- Vietnam
- East Timor
- Bangladesh
- Azerbaijan
- Kazakhstan
- Tajikistan
- Egypt
- Cyprus
- Iran
- Israel
- Lebanon
- Kuwait
- Oman
- Jordan
- Bahrain
- Qatar
- Saudi Arabia
- Syria
- UAE
- Turkey
- Pacific Islands
- Russia
- France
- UK
- Canada
- USA
- Latin America
- Africa
Rectification of the Register – A Singapore Perspective
Issued: March 29 2018
In Novartis (Singapore) Pte Ltd v. Bristol-Myers Squibb Pharma Co, the Singapore High Court addressed key procedural issues associated with corrections to patent forms and priority data, as well as corrections to the Singapore Patents Register. Gladys Mirandah and Suhaimi Bin Lazim explain.
Related Articles
- Singapore: No Snap Judgment on Similari...
- AIPPI: Is mandatory mediation good for I...
- “Raiding off Into the Sunset” – A View f...
Like China itself, the country’s enforcement environment is rapidly evolving. The old tool of raiding will never stop having a value, b...
- Intellectual Property Office of Singapor...
- Rocker Joan Jett Trademark Infringement ...
- Fighting Online Infringement
Law Firms
My Account
Most Read Articles
Magazine Issues
Tags
Baker & McKenzie USPTO WIPO DLA Piper Tilleke & Gibbins Anand and Anand TRIPS Delhi High Court Rouse IPOS Remfry & Sagar Hogan Lovells WTO PCT SIPO Spruson & Ferguson KIPO Bird & Bird Lex Orbis EPO Lall Lahiri & Salhotra Krishna & Saurastri Anaqua INTA IPAB JPO Davies Collison Cave patrick mirandah co King & Wood Mallesons AJ Park Kim & Chang Indian Patent Office Orrick Herrington & Sutcliffe Shearn Delamore & Co Deacons Madrid Protocol Tay & Partners Chang Tsi & Partners Pinsent Masons LLS Lee & Ko Khaitan & Co Blake Dawson USTR K&L Gates Drew & Napier TIPO Allen & Gledhill Griffith Hack Lee and Li